Literature DB >> 9371698

Molecular cloning, sequencing and functional study of the promoter region of the human alpha2C4-adrenergic receptor gene.

S Schaak1, J C Devedjian, C Cayla, Y Sender, H Paris.   

Abstract

Screening of a human foetal brain genomic DNA library allowed us to isolate an EcoRI-EcoRI fragment containing 6 kb of the 5'-flanking region, the open reading frame and 4 kb of the 3'-flanking region of the alpha2C4 gene. Analysis of the sequenced region (4850 bp) revealed that the first 900 bp 5' to the start codon are very rich in GC (84%), contain several Sp1-binding sites and lack a consensus TATA box. The 5'- and 3'-ends of the alpha2C4 transcript were determined by RNase-protection assays carried out with a series of antisense probes. The data obtained with cellular RNA from HepG2 cells demonstrated that transcription is initiated 891 bases upstream of the translation-start site and that the polyadenylation site is located 550 bases downstream of the stop codon. These results are consistent with the existence of a non-conventional TATA box (TTAGAAA) and the presence of a unique polyadenylation signal (AATAAA). They also fit with the size of alpha2C4-RNA found by Northern-blot analysis (2.9 kb). The transcriptional activity of the alpha2C4 promoter region was investigated by transfecting several cell types with chimaeric constructs containing various fragments of the 5'-non-coding region and luciferase as a reporter gene. The activity of the construct containing the entire 5'-non-coding region appeared to depend on the host cell. Removal of the 5'-untranslated region resulted in loss of cell specificity and a concomitant increase in luciferase activity. Transfection of HepG2 and SK-N-MC cells with constructs deleted of additional 5'-flanking fragments permitted the definition of a minimal 200 bp promoter fragment containing the pseudo-TATA box and two putative SP1-binding sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371698      PMCID: PMC1218938          DOI: 10.1042/bj3280431

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Regulation of gene expression by alternative promoters.

Authors:  T A Ayoubi; W J Van De Ven
Journal:  FASEB J       Date:  1996-03       Impact factor: 5.191

2.  Analysis of the alpha2C-adrenergic receptor gene promoter and its cell-type-specific activity.

Authors:  J S Saulnier-Blache; Q Yang; J D Sherlock; S M Lanier
Journal:  Mol Pharmacol       Date:  1996-12       Impact factor: 4.436

3.  Expression of alpha 2-adrenergic receptor genes in rat tissues.

Authors:  H S Blaxall; N A Hass; D B Bylund
Journal:  Receptor       Date:  1994

4.  An upstream stimulatory factor (USF) binding motif is critical for rat preprotachykinin-A promoter activity in PC12 cells.

Authors:  J M Paterson; C F Morrison; S C Mendelson; J McAllister; J P Quinn
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 5.  International Union of Pharmacology nomenclature of adrenoceptors.

Authors:  D B Bylund; D C Eikenberg; J P Hieble; S Z Langer; R J Lefkowitz; K P Minneman; P B Molinoff; R R Ruffolo; U Trendelenburg
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

6.  Enhanced transcription of the human alpha 2A-adrenergic receptor gene by cAMP: evidence for multiple cAMP responsive sequences in the promoter region of this gene.

Authors:  L Shilo; M Sakaue; J M Thomas; M Philip; B B Hoffman
Journal:  Cell Signal       Date:  1994-01       Impact factor: 4.315

7.  HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype.

Authors:  S Schaak; C Cayla; R Blaise; F Quinchon; H Paris
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

8.  Human adipocytes express alpha 2-adrenergic receptor of the alpha 2A-subtype only: pharmacological and genetic evidence.

Authors:  I Castan; J C Devedjian; P Valet; H Paris; M Lafontan
Journal:  Fundam Clin Pharmacol       Date:  1995       Impact factor: 2.748

9.  Transcription of the rat alpha 1B adrenergic receptor gene in liver is controlled by three promoters.

Authors:  B Gao; G Kunos
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

10.  Localization of messenger RNA for three distinct alpha 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology.

Authors:  D E Berkowitz; D T Price; E A Bello; S O Page; D A Schwinn
Journal:  Anesthesiology       Date:  1994-11       Impact factor: 7.892

View more
  5 in total

1.  Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Authors:  Kersten M Small; Jeanne Mialet-Perez; Carrie A Seman; Cheryl T Theiss; Kari M Brown; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

2.  Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.

Authors:  C Cayla; S Schaak; C Roquelaine; C Gales; F Quinchon; H Paris
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 3.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

4.  High level of alpha2-adrenoceptor in rat foetal liver and placenta is due to alpha2B-subtype expression in haematopoietic cells of the erythrocyte lineage.

Authors:  D Cussac; S Schaak; C Denis; C Flordellis; D Calise; H Paris
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors.

Authors:  A H Eid; M A Chotani; S Mitra; T J Miller; N A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.